Latest Antibiotic-resistant bacteria Stories
Unique Phenotypic Targeting Approach Provides Physicians with a Better, Faster Way to Identify MRSA and MSSA WOBURN, Mass., Nov.
LOS ANGELES, Oct.
As Public Health Preoccupies Americans, Foundation that Fights Deadly Infections Honored Leaders for Significant Contributions to Clostridium Difficile Treatment, Research and Patient Advocacy
Antimicrobial patient and staff stations installed into Western Australian private hospital, capable of a biocidal kill rate of 99% against deadly infections and superbugs. Perth,
LONDON, Oct. 15, 30, 2014 /PRNewswire/ -- Infections from activities and procedures taking place within a healthcare facility have become a cause for great concern.
Hospital visitors and staff are greeted with hand sanitizer dispensers in the lobby, by the elevators and outside rooms as reminders to wash their hands to stop infections, but just how clean are patients' hands?
Results for groundbreaking multi-center study of lead drug candidate RBX2660 (microbiota suspension) presented at IDWeek 2014 PHILADELPHIA, Oct.
LAUSANNE, Switzerland, October 7, 2014 /PRNewswire/ -- Debiopharm Group(TM)(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that
Company Completes Enrollment in Phase 2 Clinical Trial AUSTIN, Texas, Oct.
Rebiotix lead drug candidate RBX2660 (microbiota suspension) assessed in PUNCH CD study ROSEVILLE, Minn., Oct. 1, 2014 /PRNewswire/ -- Rebiotix Inc.
- totally perplexed and mixed up.